Cargando…
CAR-T Cells in Canada; Perspective on How to Ensure We Get Our Value’s Worth
New therapies in a publicly funded healthcare system are first appraised by health technology assessment agencies that provide funding recommendations to the payers. Treatment with Chimeric Antigen Receptor-T cell (CAR-T) therapy is revolutionizing the management of patients with relapsed/refractory...
Autores principales: | Villeneuve, Pierre J. A., Bredeson, Christopher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136494/ https://www.ncbi.nlm.nih.gov/pubmed/37185418 http://dx.doi.org/10.3390/curroncol30040305 |
Ejemplares similares
-
How much is my paper worth?
por: Chernoff, Jonathan
Publicado: (2019) -
How should we be selecting our graduate students?
por: Weiner, Orion D.
Publicado: (2014) -
Embracing our responsibility to ensure trainee competency
por: Santen, Sally A., et al.
Publicado: (2023) -
Moving toward multimedia electronic health records: how do we get there?
por: Seto, Belinda, et al.
Publicado: (2012) -
Healthcare in Canada's North: Are We Getting Value for Money?
por: Young, T. Kue, et al.
Publicado: (2016)